C B PHARMA ACQUISITION CORP's ticker is CNLMU and the CUSIP is G2029P100. A total of 6 filers reported holding C B PHARMA ACQUISITION CORP in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $176,000 | -0.6% | 17,300 | 0.0% | 0.00% | – |
| Q4 2015 | $177,000 | -2.7% | 17,300 | -1.1% | 0.00% | – |
| Q3 2015 | $182,000 | -0.5% | 17,500 | 0.0% | 0.00% | – |
| Q2 2015 | $183,000 | -7.6% | 17,500 | -9.8% | 0.00% | – |
| Q1 2015 | $198,000 | -1.5% | 19,400 | -3.0% | 0.00% | – |
| Q4 2014 | $201,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENECA CAPITAL INVESTMENTS, L.P. | 150,000 | $1,533,000 | 0.35% |
| Polar Asset Management Partners Inc. | 200,000 | $2,044,000 | 0.11% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 350,000 | $3,577,000 | 0.08% |
| GLAZER CAPITAL, LLC | 39,524 | $404,000 | 0.06% |
| GOLDMAN SACHS GROUP INC | 19,400 | $198,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 28 | $0 | 0.00% |